Concepedia
Statistics
Publications
23
Citations
1.7K
H-Index
Active since
2002
Affiliations
Affimed Therapeutics (Germany)(Current)
University of the Witwatersrand
German Cancer Research Center
Heidelberg University
Ludwig-Maximilians-Universität München
Stefan Knackmuss is an author at Affimed Therapeutics (Germany) specializing in oncology, medicine, and immunology.
Publications per year
2002–2021
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
Achim Rothe, Stephanie Sasse, Max S. Topp et al. · Blood · 2015 · 330 citations · Full text
Life Sciences, Immunology, Oncology +16
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30<sup>+</sup>tumor cells
Uwe Reusch, Carmen Burkhardt, Ivica Fucek et al. · mAbs · 2014 · 159 citations · Full text
Life Sciences, Immunology, Oncology +17
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19<sup>+</sup>tumor cells
Uwe Reusch, Johannes Duell, Kristina Ellwanger et al. · mAbs · 2015 · 127 citations · Full text
Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies
Matthias Eder, Björn Wängler, Stefan Knackmuss et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 102 citations
Pharmacy, Biochemistry, Medicinal Chemistry +14
Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma
Sergey M. Kipriyanov, Björn Cochlovius, Holger Schäfer et al. · The Journal of Immunology · 2002 · 90 citations · Full text
1–5 of 23